Skip to content
  • Tuesday, 27 October 2026
  • 7:06 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Biohaven and Ono Pharmaceutical Forge Up to $100m Licensing Deal for Advanced IgG Degrader Portfolio in Asia
Pharmaceutical R&D

Biohaven and Ono Pharmaceutical Forge Up to $100m Licensing Deal for Advanced IgG Degrader Portfolio in Asia

Teuku Ryan Oct 11, 2026 0

The global biopharmaceutical landscape witnessed a significant strategic alliance as Biohaven Ltd. announced a landmark licensing and regional partnership agreement…

Read More
Molecular & Cell Biology

Asia’s Towering Peaks Reveal Five Distinct Himalayan Pit Viper Species, Including Three New to Science

Angie Faith Jun 17, 2026 0

The remote and formidable mountain ranges of Asia, often described as the planet’s final frontiers for wildlife discovery, have yielded…

Read More
Pharmaceutical R&D

Everest Medicines Acquires Hasten Biopharmaceuticals for $250 Million to Bolster Asia Pacific Chronic Disease Portfolio and Commercial Reach

Teuku Ryan Apr 9, 2026 0

Everest Medicines, a leading biopharmaceutical company focused on developing and commercializing innovative medicines for chronic diseases, has announced a significant…

Read More
New Research Reveals How Local Brain Wiring May Buffer Cognitive Decline in Aging PopulationsThe newly dubbed hydrogenobody is found in ciliates living in cows’ first stomach.Yawning is contagious — even in the wombEngineered Mie Voids in Bismuth Telluride Heterostructures Enable Enhanced Light-Matter Interactions in Atomically Thin Semiconductors
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ